Patent ID: 11866510
Assignee: CRESCENDO BIOLOGICS LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 10:
11. A CAR according to claim 1 wherein said second target is selected from PSCA, BCMA, CS1, GPC3, CSPG4, EGFR, CD123, 5T4, CD23, L1 CAM, MUC16, ROR1, SLAMF7, cKit, CD19, CD20, CD22, CD33, CD38, CD53, CD92, CD100, CD148, CD150, CD200, CD261, CD262, CD362, ROR1, mesothelin, CD33/IL3Ra, c-Met, Glycolipid F77, EGFRvlll, GD-2, NY-ESO-1 TCR or MAGE A3 TCR, human telomerase reverse transcriptase (hTERT), survivin, cytochrome P450 1 B1 (CY1 B), HER2, Wilm's tumor gene 1 (WT1), livin, alphafetoprotein (AFP), carcinoembryonic antigen (CEA), mucin 16, MUC1, p53 and cyclin.